Table 1.
Subjects baseline characterization and task performance (mean ± SD)
| Women during early follicular phase | Women during midluteal phase | Men | |
|---|---|---|---|
| Number of subjects | 12 | 12 | 12 |
| Age | 30.8 ± 5.0 | 30.8 ± 5.0 | 33.2 ± 6.2 |
| Intelligence, more visuo-spatially based estimate measure (CFT) | 118.3 ± 13.7 | 118.3 ± 13.7 | 124.0 ± 10.2 |
| Intelligence, more verbally based estimate measure (MWT-B) | 112.0 ± 13.6 | 112.0 ± 13.6 | 117.0 ± 11.9 |
| Testosterone in ng/mla | 0.34 ± 0.13 | 0.37 ± 0.13 | 5.10 ± 1.45* |
| Estradiol in pg/mlb | 46.75 ± 11.10* | 129.00 ± 56.81* | 36.0 ± 6.30* |
| Progesterone in ng/mlc | 0.65 ± 0.15 | 10.02 ± 5.70* | 0.70 ± 0.20 |
| Reproduction Quantity score | 47.7 ± 21.0 | 48.3 ± 18.9 | 50.8 ± 22.3 |
| Reproduction Quality score | 9.3 ± 4.0 | 9.8 ± 3.1 | 10.2 ± 2.8 |
| Reproduction Quality/quality ratio | 0.23 ± 0.12 | 0.24 ± 0.14 | 0.23 ± 0.09 |
| Novel generation Quantity score | 40.6 ± 19.3 | 44.8 ± 16.8 | 44.7 ± 15.7 |
| Novel generation Quality score | 4.7 ± 1.4 | 6.6 ± 2.1 | 5.9 ± 2.0 |
| Novel generation Quality/quality ratio | 0.16 ± 0.15 | 0.17 ± 0.09 | 0.14 ± 0.06 |
T tests between groups are not significant if not indicated otherwise. *Value differs significantly from value in other groups
a For women during the early follicular phase and women during the midluteal phase versus men P < 0.001
bFor women during the early follicular phase versus men P = 0.008. For women during the midluteal phase versus men P < 0.001 and versus women during the early follicular phase P < 0.001
cFor women during the midluteal phase versus men P < 0.001 and versus women during the early follicular phase P < 0.001